Inozyme Pharma Inc Share Price

NASDAQ: INZY

$4.00

(+0.13%)

as on July 1, 2025 at 1:29 am IST

$₹

The stock has been delisted from the stock exchange on 30 Jun 2025

Inozyme Pharma Inc Stock Performance

as on July 1, 2025 at 1:29 am IST

$4
Day's Price Range
$4
$4
52 Week's Low
52 Week's High
$0.72
52-Week Price Range
$6.24
$4
81.97%
Downside
56.00%
Upside

Inozyme Pharma Inc share price movements today

Previous Close: $3.99
Open: $4.00
Volume: 1.4K
Day's Low - High: $4 - $4
52 Week Low - High: $0.72 - $6.24

Inozyme Pharma Inc Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Inozyme Pharma Inc Stock Fundamentals & Key Indicators

Check Inozyme Pharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

Return On Equity TTM

0.00%

Inozyme Pharma Inc stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Inozyme Pharma Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Inozyme Pharma Inc	BUY	$-	NA	NA	0.00%

Analyst Recommendation on Inozyme Pharma Inc Stock

Based on 13 analysts

BUY

92.31%

Buy

7.69%

Hold

0.00%

Sell

Based on 13 analysts, 92.31% of analysts recommend a 'BUY' rating for Inozyme Pharma Inc. Average target price of $4

Inozyme Pharma Inc Share Price Target

Get share price movements and forecasts by analysts on Inozyme Pharma Inc.

Target Price

Current Price

Analyzed by

13 Analysts

Target

$4.00

Inozyme Pharma Inc target price $4, a slight upside of 0% compared to current price of $4. According to 13 analysts rating.

Inozyme Pharma Inc Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Total Revenue	-	-	-	-	1	-	-	-	-	-
Gross Profit	0	0	0	0	1	0	0	0	-	-
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-18	-16	-15	-16	-21	-23	-27	-24	-27	-28
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-1090.28%	0.00%	0.00%	0.00%	0.00%	0.00%

Inozyme Pharma Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-	-
Gross Profit	0	0	0	-1	-1	-1	-
Operating Income	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-
Net Income	-6	-18	-55	-56	-65	-71	-102
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Global Institutional Holdings in Inozyme Pharma Inc

Funds	Holdings
Adage Capital Partners Gp LLC	7.99%
Pivotal bioVenture Partners Investment Advisor LLC	6.96%
Sofinnova Ventures	6.63%
Affinity Asset Advisors, LLC	5.99%
BlackRock Inc	5.8%

See all

About Inozyme Pharma Inc

Inozyme Pharma, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing therapeutics that target the pyrophosphate (PPi)-Adenosine Pathway, a key regulator of bone health and blood vessel function. Its lead product candidate, INZ-701, is a soluble, recombinant, or genetically engineered, ENPP1 fusion protein that is designed to increase PPi and adenosine, to enable the potential treatment of multiple diseases caused by deficiencies in these molecules. The Company is conducting clinical trials of INZ-701 for the treatment of Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) Deficiency, ATP-Binding Cassette in the C6 family (ABCC6) Deficiency, and calciphylaxis. The Company also plans to investigate the potential of a next generation INZ-701 molecule to address posterior longitudinal ligament (OPLL).

Organisation	Inozyme Pharma Inc
E-voting on shares	Click here to vote

FAQs

What is Inozyme Pharma Inc share price today?

Inozyme Pharma Inc share price today is $4 as on July 1, 2025 at 1:29 am IST at the close of the market. Inozyme Pharma Inc share today touched a day high of $4 and a low of $4.

What is the 52 week high and 52 week low for Inozyme Pharma Inc share?

Inozyme Pharma Inc share touched a 52 week high of $6.24 on September 17, 2024 and a 52 week low of $0.72 on April 7, 2025. Inozyme Pharma Inc stock price today i.e. July 1, 2025 at 1:29 am IST is closed at $4,which is 35.90% down from its 52 week high and 454.79% up from its 52 week low.

How to invest in Inozyme Pharma Inc Stock (INZY) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Inozyme Pharma Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Inozyme Pharma Inc Shares that will get you 0.3750 shares as per Inozyme Pharma Inc share price of $4 per share as on July 1, 2025 at 1:29 am IST.

What is the minimum amount required to buy Inozyme Pharma Inc Stock (INZY) from India?

Indian investors can start investing in Inozyme Pharma Inc (INZY) shares with as little as ₹88.27 or $1 (as of September 15, 2025 at 3:56 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Inozyme Pharma Inc stock (as per the Rupee-Dollar exchange rate as on September 15, 2025 at 3:56 pm IST). Based on Inozyme Pharma Inc share’s latest price of $4 as on July 1, 2025 at 1:29 am IST, you will get 2.5000 shares of Inozyme Pharma Inc. Learn more about fractional shares .